An explainer on how appetite and weight can change after coming off GLP-1 drugs, and why any taper should be done with a doctor guiding it.
Recap by typeshit. Post by U.S. News Health on X.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A quick clip from Dr Nadolsky with a single recommendation for people on GLP-1 drugs. The habit itself isn't named in the caption.
With GLP-1 medications already shifting what people buy, the piece asks what happens to the morning meal and the brands that sell it.
Loading…